SCZD vs non-psychiatric controls without qSVA
=============================================



## Enriched GOs (without qSVA)

![Enriched BP](pdf/go_de_genes_Page_1.png)
![Enriched MF](pdf/go_de_genes_Page_2.png)
![Enriched CC](pdf/go_de_genes_Page_3.png)
![Enriched KEGG pathways](pdf/go_de_genes_Page_4.png)

## With vs without qSVA

![HIPPO no qSVA vs HIPPO with qSVA](pdf/scatter_models_Page_6.png)
![DLPFC no qSVA vs DLPFC with qSVA](pdf/scatter_models_Page_7.png)


## More

| without qSVA  | with qSVA  |
|---|---|
| ![HIPPO no qSVA vs DLPFC no qSVA](pdf/scatter_models_Page_1.png)  | ![HIPPO with qSVA vs DLPFC no qSVA](pdf/original/scatter_models_Page_1.png)  |
| ![HIPPO no qSVA vs BSP1](pdf/scatter_models_Page_2.png)  | ![HIPPO with qSVA vs BSP1](pdf/original/scatter_models_Page_2.png)  |
| ![HIPPO no qSVA vs CMC](pdf/scatter_models_Page_3.png)  |  ![HIPPO with qSVA vs CMC](pdf/original/scatter_models_Page_3.png) |
| ![DLPFC no qSVA vs BSP1](pdf/scatter_models_Page_4.png)  |  ![DLPFC with qSVA vs BSP1](pdf/original/scatter_models_Page_4.png) |
| ![DLPFC no qSVA vs CMC](pdf/scatter_models_Page_5.png)  |  ![DLPFC with qSVA vs CMC](pdf/original/scatter_models_Page_5.png) |



